We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSP icon
2401
Insperity
NSP
$1.94B
$710K ﹤0.01%
5,817
+177
+3% +$21.3K
BME icon
2402
BlackRock Health Sciences Trust
BME
$577M
$709K ﹤0.01%
18,223
-1,425
-7% -$54.2K
IBOC icon
2403
International Bancshares
IBOC
$4.48B
$707K ﹤0.01%
18,742
-1,000
-5% -$39.2K
BMI icon
2404
Badger Meter
BMI
$3.93B
$706K ﹤0.01%
11,834
-7,535
-39% -$418K
NHC icon
2405
National Healthcare
NHC
$3.39B
$706K ﹤0.01%
8,701
+204
+2% +$15.7K
EXI icon
2406
iShares Global Industrials ETF
EXI
$1.48B
$705K ﹤0.01%
+7,694
New +$695K
SVC
2407
Service Properties Trust
SVC
$1.05B
$704K ﹤0.01%
5,629
-1,030
-15% -$132K
TCF
2408
DELISTED
TCF Financial Corporation
TCF
$704K ﹤0.01%
33,847
+5,520
+19% +$115K
FATE icon
2409
Fate Therapeutics
FATE
$319M
$703K ﹤0.01%
34,638
+2,090
+6% +$37.7K
X
2410
DELISTED
US Steel
X
$703K ﹤0.01%
45,947
-13,525
-23% -$208K
AADR icon
2411
AdvisorShares Dorsey Wright ADR ETF
AADR
$38.7M
$701K ﹤0.01%
14,099
+6,304
+81% +$294K
INF
2412
DELISTED
BROOKFIELD GLOBAL LISTED INFRASTRUCTURE INCOME FUND INC.
INF
$701K ﹤0.01%
54,732
+6,385
+13% +$79.5K
EZM icon
2413
WisdomTree US MidCap Fund
EZM
$951M
$700K ﹤0.01%
17,497
+605
+4% +$24K
LASR icon
2414
nLIGHT
LASR
$2.84B
$700K ﹤0.01%
36,472
-7,346
-17% -$161K
BBDC icon
2415
Barings BDC
BBDC
$975M
$698K ﹤0.01%
70,930
+6,594
+10% +$65.7K
FOLD
2416
DELISTED
Amicus Therapeutics
FOLD
$698K ﹤0.01%
55,927
+5,747
+11% +$72.9K
EE
2417
DELISTED
El Paso Electric Company
EE
$697K ﹤0.01%
10,660
-4,406
-29% -$270K
GHDX
2418
DELISTED
Genomic Health, Inc.
GHDX
$696K ﹤0.01%
11,972
-4,086
-25% -$242K
IPKW icon
2419
Invesco International BuyBack Achievers ETF
IPKW
$554M
$695K ﹤0.01%
21,811
+115
+0.5% +$3.66K
INDA icon
2420
iShares MSCI India ETF
INDA
$6.6B
$693K ﹤0.01%
19,627
-4,916
-20% -$173K
ARDC
2421
Are Dynamic Credit Allocation Fund
ARDC
$298M
$692K ﹤0.01%
45,750
+10,381
+29% +$157K
GHL
2422
DELISTED
Greenhill & Co., Inc.
GHL
$692K ﹤0.01%
50,928
-39,575
-44% -$726K
KRG icon
2423
Kite Realty
KRG
$5.24B
$691K ﹤0.01%
45,655
+722
+2% +$11.4K
PDN icon
2424
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$365M
$691K ﹤0.01%
23,165
+33
+0.1% +$985
AEPPL
2425
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
$689K ﹤0.01%
+12,870
New +$674K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.